February 01, 2013 at 06:52 AM EST
VIVUS (VVUS) Shares Jump After Qsymia Study Results
VIVUS Inc. (NASDAQ: VVUS) said a study concluded its weight-loss drug Qsymia significantly improved multiple cardiovascular disease risk factors, and its shares jumped 6.11 percent in premarket trading on Friday. [More...]
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here